Correction to: Adv Ther (2021) 38:3550–3588 https://doi.org/10.1007/s12325-021-01761-3
The original article was published with an error regarding response to vaccination with ozanimod on page 3561 and in Table 4. The correct sentence and Table 4 are given below
The few data available for other S1P receptor modulators suggest there can be some negative impact on vaccine response (145).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coyle, P.K., Gocke, A., Vignos, M. et al. Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era. Adv Ther 39, 822–830 (2022). https://doi.org/10.1007/s12325-021-01967-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-021-01967-5